vs

Side-by-side financial comparison of IDEX Corporation (IEX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $220.8M, roughly 1.8× UNIVERSAL TECHNICAL INSTITUTE INC). IDEX Corporation runs the higher net margin — 30.1% vs 5.8%, a 24.3% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (16.7% vs 9.6%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs -29.4%).

IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

IEX vs UTI — Head-to-Head

Bigger by revenue
IEX
IEX
1.8× larger
IEX
$398.4M
$220.8M
UTI
Growing faster (revenue YoY)
IEX
IEX
+7.0% gap
IEX
16.7%
9.6%
UTI
Higher net margin
IEX
IEX
24.3% more per $
IEX
30.1%
5.8%
UTI
More free cash flow
IEX
IEX
$105.2M more FCF
IEX
$86.0M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
-29.4%
IEX

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
IEX
IEX
UTI
UTI
Revenue
$398.4M
$220.8M
Net Profit
$120.0M
$12.8M
Gross Margin
99.9%
Operating Margin
43.3%
7.1%
Net Margin
30.1%
5.8%
Revenue YoY
16.7%
9.6%
Net Profit YoY
25.7%
-42.1%
EPS (diluted)
$1.61
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IEX
IEX
UTI
UTI
Q2 26
$398.4M
Q1 26
$407.7M
Q4 25
$899.1M
$220.8M
Q3 25
$878.7M
$222.4M
Q2 25
$865.4M
$204.3M
Q1 25
$814.3M
$207.4M
Q4 24
$862.9M
$201.4M
Q3 24
$798.2M
$196.4M
Net Profit
IEX
IEX
UTI
UTI
Q2 26
$120.0M
Q1 26
$128.3M
Q4 25
$128.3M
$12.8M
Q3 25
$127.8M
$18.8M
Q2 25
$131.6M
$10.7M
Q1 25
$95.5M
$11.4M
Q4 24
$123.2M
$22.2M
Q3 24
$119.1M
$18.8M
Gross Margin
IEX
IEX
UTI
UTI
Q2 26
99.9%
Q1 26
94.9%
Q4 25
43.1%
Q3 25
44.5%
Q2 25
45.3%
Q1 25
45.3%
Q4 24
42.5%
Q3 24
44.3%
Operating Margin
IEX
IEX
UTI
UTI
Q2 26
43.3%
Q1 26
45.0%
Q4 25
20.4%
7.1%
Q3 25
21.1%
11.2%
Q2 25
21.7%
6.9%
Q1 25
17.4%
8.1%
Q4 24
19.2%
13.6%
Q3 24
21.0%
13.3%
Net Margin
IEX
IEX
UTI
UTI
Q2 26
30.1%
Q1 26
31.5%
Q4 25
14.3%
5.8%
Q3 25
14.5%
8.4%
Q2 25
15.2%
5.2%
Q1 25
11.7%
5.5%
Q4 24
14.3%
11.0%
Q3 24
14.9%
9.6%
EPS (diluted)
IEX
IEX
UTI
UTI
Q2 26
$1.61
Q1 26
$1.71
Q4 25
$1.71
$0.23
Q3 25
$1.70
$0.33
Q2 25
$1.74
$0.19
Q1 25
$1.26
$0.21
Q4 24
$1.61
$0.40
Q3 24
$1.57
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IEX
IEX
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$586.2M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$4.0B
$335.9M
Total Assets
$6.9B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IEX
IEX
UTI
UTI
Q2 26
$586.2M
Q1 26
$580.0M
Q4 25
$580.0M
$162.8M
Q3 25
$593.8M
$169.1M
Q2 25
$568.2M
$70.7M
Q1 25
$594.1M
$96.0M
Q4 24
$620.8M
$172.0M
Q3 24
$633.2M
$161.9M
Total Debt
IEX
IEX
UTI
UTI
Q2 26
Q1 26
Q4 25
$1.8B
$101.4M
Q3 25
$1.9B
$87.1M
Q2 25
$1.9B
$73.8M
Q1 25
$2.0B
$94.4M
Q4 24
$2.0B
$120.1M
Q3 24
$2.1B
$125.7M
Stockholders' Equity
IEX
IEX
UTI
UTI
Q2 26
$4.0B
Q1 26
$4.0B
Q4 25
$4.0B
$335.9M
Q3 25
$4.0B
$328.1M
Q2 25
$4.0B
$306.8M
Q1 25
$3.9B
$293.9M
Q4 24
$3.8B
$280.0M
Q3 24
$3.8B
$260.2M
Total Assets
IEX
IEX
UTI
UTI
Q2 26
$6.9B
Q1 26
$6.9B
Q4 25
$6.9B
$834.0M
Q3 25
$7.0B
$826.1M
Q2 25
$6.9B
$740.8M
Q1 25
$6.8B
$720.4M
Q4 24
$6.7B
$753.8M
Q3 24
$7.0B
$744.6M
Debt / Equity
IEX
IEX
UTI
UTI
Q2 26
Q1 26
Q4 25
0.45×
0.30×
Q3 25
0.48×
0.27×
Q2 25
0.46×
0.24×
Q1 25
0.50×
0.32×
Q4 24
0.52×
0.43×
Q3 24
0.55×
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IEX
IEX
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$86.0M
$-19.2M
FCF MarginFCF / Revenue
21.6%
-8.7%
Capex IntensityCapex / Revenue
4.4%
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$654.3M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IEX
IEX
UTI
UTI
Q2 26
Q1 26
Q4 25
$209.5M
$3.1M
Q3 25
$203.5M
$57.1M
Q2 25
$161.7M
$18.1M
Q1 25
$105.7M
$-789.0K
Q4 24
$172.6M
$23.0M
Q3 24
$205.3M
$67.5M
Free Cash Flow
IEX
IEX
UTI
UTI
Q2 26
$86.0M
Q1 26
$189.8M
Q4 25
$189.8M
$-19.2M
Q3 25
$188.7M
$40.6M
Q2 25
$146.9M
$6.8M
Q1 25
$91.4M
$-11.7M
Q4 24
$157.1M
$19.6M
Q3 24
$191.6M
$60.0M
FCF Margin
IEX
IEX
UTI
UTI
Q2 26
21.6%
Q1 26
46.6%
Q4 25
21.1%
-8.7%
Q3 25
21.5%
18.3%
Q2 25
17.0%
3.4%
Q1 25
11.2%
-5.7%
Q4 24
18.2%
9.7%
Q3 24
24.0%
30.6%
Capex Intensity
IEX
IEX
UTI
UTI
Q2 26
4.4%
Q1 26
15.6%
Q4 25
2.2%
10.1%
Q3 25
1.7%
7.4%
Q2 25
1.7%
5.5%
Q1 25
1.8%
5.3%
Q4 24
1.8%
1.7%
Q3 24
1.7%
3.8%
Cash Conversion
IEX
IEX
UTI
UTI
Q2 26
Q1 26
Q4 25
1.63×
0.24×
Q3 25
1.59×
3.04×
Q2 25
1.23×
1.69×
Q1 25
1.11×
-0.07×
Q4 24
1.40×
1.04×
Q3 24
1.72×
3.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IEX
IEX

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons